HAYWARD, Calif., Mar 04, 2010 (BUSINESS WIRE) --
Impax Laboratories, Inc.(NASDAQ: IPXL) today announced
that the Company will provide an update of their business at the Cowen &
Co. 30th Annual Health Care Conference on Tuesday, March 9th,
at 3:45 p.m. Eastern Standard time. The conference will be held at The
Boston Marriott Copley Place, Boston, MA.
Individuals may listen to the live or an archived presentation made at
the conferences, which will be posted in the investor relations section
of the Company's web site at www.impaxlabs.com.
This presentation will be archived on the Company's web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology
to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its
generic products through its Global Pharmaceuticals division and markets
its branded products through the Impax Pharmaceuticals division.
Additionally, where strategically appropriate, Impax has developed
marketing partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a full
range of capabilities in its Hayward and Philadelphia facilities. For
more information, please visit the Company's Web site at: www.impaxlabs.com.
SOURCE: Impax Laboratories, Inc.
Impax Laboratories, Inc.
Mark Donohue
Sr. Director, Investor Relations and Corporate Communications
(215) 933-3526
www.impaxlabs.com